Mode
Text Size
Log in / Sign up

Cardiology

835 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Systematic review and meta-analysis of erythropoiesis-stimulating agents in chronic heart failure and anaemia
Cardiology Meta-analysis
Systematic review and meta-analysis of erythropoiesis-stimulating agents in chronic heart failure and anaemia New drugs help heart failure patients stay out of the hospital
This systematic review and meta-analysis evaluated erythropoiesis-stimulating agents (ESAs) in adults with chronic heart failure and anaemia…
A new review shows specific drugs can keep heart failure patients out of the hospital while improving their daily energy and movement.
Qiliqiangxin reduces cardiovascular events in heart failure with reduced ejection fraction across LVEF subgroups
Cardiology RCT
Qiliqiangxin reduces cardiovascular events in heart failure with reduced ejection fraction across LVEF subgroups Lower heart function gets worse care but this drug helps everyone equally
This post hoc analysis of a Phase 3 RCT in 3110 patients with symptomatic HFrEF found that adding qiliqiangxin to guideline-directed therapy…
This heart drug works for patients with weak hearts just as well as it does for those with slightly stronger pumps
Cardiac rehabilitation reduces major adverse cardiac events and mortality in coronary artery disease patients after PCI
Cardiology Meta-analysis
Cardiac rehabilitation reduces major adverse cardiac events and mortality in coronary artery disease patients after PCI After a Heart Attack, This Simple Program Could Save Your Life
This meta-analysis evaluated cardiac rehabilitation versus control in patients with coronary artery disease following percutaneous coronary …
A structured exercise and education program after heart stent surgery slashes the risk of dying from heart disease by nearly a third, a majo…
Meta-analysis finds no mortality difference for PCI with surgical backup
Cardiology Meta-analysis
Meta-analysis finds no mortality difference for PCI with surgical backup Heart Procedure Safe Without Surgery Team On Site
A meta-analysis examined percutaneous coronary intervention outcomes with and without surgical on-site backup. It found no significant diffe…
Major heart procedures are just as safe in hospitals without on-site heart surgeons, a large new review finds.
MUSKARDIA shows protective trend in stable CAD with reduced eGFR
Cardiology RCT
MUSKARDIA shows protective trend in stable CAD with reduced eGFR This Heart Pill from Traditional Medicine Shows Surprising Kidney Protection
A subgroup analysis of a phase IV trial found MUSKARDIA may protect against cardiovascular events in stable CAD patients with reduced kidney…
A traditional Chinese medicine pill already used for heart disease may also shield the kidneys, offering new hope for millions with both con…
Sex differences in outcomes after stroke in NVAF with ASCVD: a post hoc analysis
Cardiology RCT
Sex differences in outcomes after stroke in NVAF with ASCVD: a post hoc analysis Women and Men With AFib and Clogged Arteries Share Same Stroke Risk
This post hoc analysis of an RCT included 222 patients with recent ischemic stroke or TIA, NVAF, and ASCVD. No significant sex differences w…
Women and men with AFib and clogged arteries face similar risks for stroke, heart attack, and bleeding over two years.
Sacubitril/Valsartan plus RFCA improves rhythm control in hypertensive NPAF patients
Cardiology RCT
Sacubitril/Valsartan plus RFCA improves rhythm control in hypertensive NPAF patients ARNI plus RFCA improves heart rhythm control in hypertension patients
This randomized controlled trial in 240 hypertensive patients with nonparoxysmal atrial fibrillation compared sacubitril/valsartan plus radi…
Adding sacubitril/valsartan to a heart procedure helped more patients stay in normal rhythm and lowered blood pressure markers.
Review of antibody-based strategies against RSV and SARS-CoV-2 in infants
Cardiology Sys. Review
Review of antibody-based strategies against RSV and SARS-CoV-2 in infants New antibody treatments for babies lower virus hospitalization risk greatly
This narrative review examines antibody-based strategies against respiratory syncytial virus and SARS-CoV-2 in infants. It reports that nirs…
A review of antibody treatments for babies shows they greatly lower hospitalization risk from respiratory viruses. These medicines stay effe…
Meta-analysis finds intravascular imaging reduces MACE in older PCI patients
Cardiology Meta-analysis
Meta-analysis finds intravascular imaging reduces MACE in older PCI patients New imaging tools lower heart attack risk for seniors during stent procedures
This meta-analysis of RCTs in adults aged 65 years or older undergoing PCI found that intravascular imaging guidance significantly reduced m…
A new look at heart procedures shows that seeing inside arteries saves older adults from serious heart attacks.
Family history, prior arrhythmia, and anterior infarct location independently raise risk of ventricular fibrillation in STEMI patients
Cardiology Meta-analysis
Family history, prior arrhythmia, and anterior infarct location independently raise risk of ventricular fibrillation in STEMI patients Family history and heart attack location raise risk of dangerous heart rhythms in young patients
This meta-analysis of 1807 cases and 2923 controls confirms that family history of sudden death, previous atrial fibrillation, and anterior …
A large study found that family history of sudden death, past atrial fibrillation, and front heart attacks increase the chance of dangerous …
Meta-Analysis Identifies Risk Factors for Adverse Outcomes in MINOCA Patients
Cardiology Meta-analysis
Meta-Analysis Identifies Risk Factors for Adverse Outcomes in MINOCA Patients Old heart risk rules fail for this specific chest pain mystery
A meta-analysis of 12,081 patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) found that older age, diabetes…
New data shows that standard heart risk factors do not predict outcomes for patients with heart attacks and clear arteries.
Beta-blockers show no mortality benefit in MI patients with preserved ejection fraction
Cardiology Meta-analysis
Beta-blockers show no mortality benefit in MI patients with preserved ejection fraction Beta-blockers do not lower death risk for heart attack patients with strong heart pumps
This meta-analysis of 23,524 adults with myocardial infarction and left ventricular ejection fraction ≥ 40% found that beta-blockers did not…
A large review found beta-blockers did not reduce death or heart failure in adults with heart attacks and normal heart function.